Prof Marcel Nold |
Neonatologist and
immunologist Professor Marcel Nold from the Department of Paediatrics is
collaborating with Associate Professor Claudia Nold, pharmacist and
immunologist, Hudson Institute, and Professor James Whisstock and Dr Andrew
Ellisdon, protein biochemists and molecular biologists from the Biomedicine
Discovery Institute (BDI).
“We have made
groundbreaking discoveries on signalling mechanisms of anti-inflammatory
mediators, whose immense potential benefit for millions of patients worldwide
with a broad spectrum of diseases was immediately recognised by Hoffmann-La
Roche Ltd (Roche) of Basel, Switzerland, and by the venture capital-backed
Medical Research Commercialisation Fund (MRCF),” Professor Nold said.
“To advance our team’s
innovations and pertinent IP along the drug development pathway towards the
first-in-man stage, Roche has engaged in a multi-million dollar collaboration.”
To achieve a similar goal
for a second innovation, the team joined forces with Professor Eric Morand,
clinician-scientist and Head, SCS, and founded a company that is supported by
the MRCF.
No comments:
Post a Comment